Search research articles
Contact Us
Filters
Showing results (101-110 of 125) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1993
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma
D J Sugarbaker, G M Strauss, T J Lynch, et al.
Oncogene
|
December 7, 2010
AXL regulates mesothelioma proliferation and invasiveness
W-B Ou, J M Corson, D L Flynn, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B
N J Vogelzang, M Goutsou, J M Corson, et al.
Cancer
|
February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study
K H Antman, R H Blum, R E Wilson, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
November 1, 1986
Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials
R E Wilson, W C Wood, H L Lerner, et al.
Cancer
|
April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
B L Samuels, J E Herndon, D C Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
A P Chahinian, K Antman, M Goutsou, et al.
The New England Journal of Medicine
|
February 14, 1991
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors
J A Fletcher, H P Kozakewich, F A Hoffer, et al.
Cancer
|
June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B
N J Yogelzang, J E Herndon, C Cirrincione, et al.
Neonatology
|
August 9, 2007
Effects of lipid-supplemented total parenteral nutrition on fatty liver disease in a premature neonatal piglet model
Matthew J Hyde, Encarnación Amusquivar, John Laws, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 125) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1993
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma
D J Sugarbaker, G M Strauss, T J Lynch, et al.
Oncogene
|
December 7, 2010
AXL regulates mesothelioma proliferation and invasiveness
W-B Ou, J M Corson, D L Flynn, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B
N J Vogelzang, M Goutsou, J M Corson, et al.
Cancer
|
February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study
K H Antman, R H Blum, R E Wilson, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
November 1, 1986
Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials
R E Wilson, W C Wood, H L Lerner, et al.
Cancer
|
April 29, 1998
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B
B L Samuels, J E Herndon, D C Harmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
A P Chahinian, K Antman, M Goutsou, et al.
The New England Journal of Medicine
|
February 14, 1991
Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors
J A Fletcher, H P Kozakewich, F A Hoffer, et al.
Cancer
|
June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B
N J Yogelzang, J E Herndon, C Cirrincione, et al.
Neonatology
|
August 9, 2007
Effects of lipid-supplemented total parenteral nutrition on fatty liver disease in a premature neonatal piglet model
Matthew J Hyde, Encarnación Amusquivar, John Laws, et al.
Page
of 13